Lv2
136 积分 2026-09-17 加入
A proposal for expedited stem cell transplantation for TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
14天前
已完结
Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS
19天前
已完结
XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies
22天前
已完结
Hallmarks of immunosenescence and their clinical impact [J]. Nature Reviews Immunology
23天前
已关闭
Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms
28天前
已完结
Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study
28天前
已完结
Genomic architecture distinguishes del(5q) in therapy‑related MDS from de‑novo isolated 5q‑ MDS
28天前
已关闭
Cytogenetic patterns and transplant outcomes in therapy‑related versus de‑novo MDS
28天前
已完结
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
1个月前
已完结
Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis
1个月前
已完结
皖公网安备34019202002308
